Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Using block chain technology, Nebeus is a growing cryptographic platform for the global stage. Nearly 30,000 wallets are active, which has resulted in £1.9m of P2P bitcoin loans facilitated on the service since 2017. The company has launched a cryto-card for users to utilise both cryto currency, as well as fiat money. Nebeus currently operates in 45 countries with over £30m transactions to date and plans to expand into other major markets soon.
days to go:
Expired
investment:
£1,211,700
An app to help local independent businesses gain more exposure on the High Street. Sizzl will create bespoke marketing by using cinematography to tell stories for locals in the area to view on their smartphones. Investment will provide Sizzl with the infrastructure for a monthly subscription payment system and initial marketing to attract small businesses.
days to go:
Expired
investment:
£25,490
Black Bee Honey offer a selection of raw, single origin British honey. The entrepreneurial due previously had success with London Postcode Honey and are using this experience to help them reach their target of listing in 150 independent retailers with 26,000 units sold by 2018.
days to go:
Expired
investment:
£111,040
Currently we manufacture, market, sell and distribute consistently high quality ales in South East Dorset. Our portfolio contains a diverse range of 8 ales, one of which won a silver medal at the "2015 International Brewing Awards." The company branding is very strong and facilitates sales of the product and high value merchandise. Voted best new business 2014 in Dorset Magazine's Food, Drink and Farming Awards. Temporarily brewing in spare capacity at Lyme Regis Brewery.
days to go:
Expired
investment:
£149,634
Drop Bear Beer Co. aims in disrupting and exciting the alcohol-free beer market. It is the only female-run alcohol-free craft beer company. Drop Bear Beer Co.'s May 2019 launch was a success as it experienced sales of 3000 units in one month. The company is a winner of the Wales Start-Up of the Year Awards 2019. With the proceeds, Drop Bear Beer Co. will finalise core range within 12 months, scale-up production, make range available in cans, and arrange a large brand-building campaign.
days to go:
Expired
investment:
£172,570
